US Food and Drug Administration Recommendations on the Use of Surrogate Measures as End Points in New Anti-infective Drug Approvals.

Persons

Aaron Seth Kesselheim

Venue / Journal

JAMA Intern Med

Date

Wed, 01/01/2020 - 12:00

Additional Journal Information

180(1):131-138

Authors

Hey SP, Kesselheim AS, Patel P, Mehrotra P, Powers JH.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/31710344